|
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk Clinical research trials and A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk. A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk clinical trial. Test subjects typically receive the most effective healthcare possible for their A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk  A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
For Condition: Diabetic Foot Ulcers
Status: No longer recruiting
Sponsor(s): Department of Veterans Affairs ,
Synopsis: This project will identify risk factors for diabetic foot ulcer by studying the relationship between endothelial dysfunction and foot ulcer risk. A fundamental defect in type 1 and 2 diabetic subjects is impaired vasodilatory reserve which is reflected in the dysfunction of endothelium-dependent vasodilation. Findings thus far point to an important role of the microvasculature in the development of diabetic foot ulcer and amputation. In this study a a well-characterized cohort of 750 diabetic veterans without foot ulcer will be followed over 3-years.
Details: Prevention of foot ulcer should result in a reduction in the risk of lower limb amputation. We propose to identify risk factors for diabetic foot ulcer by studying the relationship between endothelial dysfunction and foot ulcer risk. It has been proposed that impaired vasoregulation in diabetic patients leads to the development and perpetuation of chronic foot ulceration via failure of the normal hyperemic response to injury. A fundamental defect that has been demonstrated in type 1 and 2 diabetic subjects is impaired vasodilatory reserve, which reflects dysfunction of endothelium-dependent vasodilation. Our findings thus far point to an important role of the microvasculature in the development of diabetic foot ulcer and amputation, with our demonstration of higher foot ulcer and lower-limb amputation risk in relation to lower dorsal foot transcutaneous oxygen level. The role of endothelial dysfunction in relation to diabetic foot ulcer risk has not previously been studied. We will follow a well-characterized cohort of 750 diabetic veterans without foot ulcer over 3-year after obtaining baseline measures of endothelial function using iontophoretic application of acetylcholine to induce cutaneous endothelium-dependent vasodilation on the dorsal foot. Iontophoresis permits noninvasive delivery of ionic drugs cutaneously without damage to the skin or systemic effects. Change in microvascular flow will be measured using a laser Doppler imager (Moor LDI) over a 4x4 cm area divided into 18496 measurement sites. Endothelial function will be defined as the difference between readings before and after the iontophoretic application of a 1% acetylcholine solution at a current of 0.2 mA for 1 minute, with higher readings reflecting better endothelial function. These techniques are the accepted standard method for assessment of endothelium-dependent vasodilation in the cutaneous microvasculature. Additional measurements will be obtained on other ulcer risk factors to assess whether endothelial dysfunction independently influences foot ulcer risk, or whether it is merely a marker for different pathophysiologic conditions responsible for higher risk (eg., sensory neuropathy). Possible confounding factors considered will include sensory and autonomic neuropathy; dorsal foot transcutaneous oximetry; macrovascular function assessed with Doppler blood pressures; diabetes characteristics; in-shoe plantar pressure (F-scan), medication use, and foot deformity.
Eligibility:
Study Type: Observational, Screening, Longitudinal, Defined Population, Prospective Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Diabetic patients with foot ulcers
Total Enrollment: 750
Location and Contact Information:
Overall Study Official:
JohnFryer, , Program Analysis and Review Section (PARS), Rehabilitation Research & Development Service
VAMC, Seattle, WA
Seattle, Washington,
United States
Additional Information:
Study ID Numbers: A2016;
Study Start Date: October 1999
Record last reviewed: January 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013286
Other Diabetic Foot Ulcers Studies:
1. Gene Therapy to Improve Wound Healing in Patients With Diabetes
2. A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
3. Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing
4. Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers with Regranex or Placebo
5. Clinical Trials of Footwear in Patients with Diabetes-Study Arm 2,3
Related Studies:
Other Diabetic Foot Ulcers Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
|
|
|
|
|
|
|
|
